MIV Therapeutics, Inc.
Profile
Mailing Address: 1-8765 Ash Street
Vancouver, BC
V6P 6T3
Head Office Address: 1-8765 Ash Street
Vancouver, BC
V6P 6T3
Contact Name: Dr. Mark Landy Principal Regulator: British Columbia
Business e-mail address: mark.landy@mivtinc.com Short Form Prospectus Issuer: No
Telephone Number: 604 301-9545 Reporting Jurisdictions: British Columbia, Other than Canada
Fax Number: Stock Exchange: OTCBB
Date of Formation: Mar 19 1999 Stock Symbol: MIVI
Jurisdiction Where Formed: Nevada Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 55306V Transfer Agent: Interwest Stock Transfer Co. Inc.
Financial Year-End: May 31 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents